Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...

Mesenchymal stem cells have been explored across a wide range of diseases due to their potential to reduce inflammation and ...

Roche has conditional marketing authorisation from the EC for Lunsumio SC for adults with R/R FL after at least two systemic ...

Moderna has announced the expansion of its US manufacturing capabilities with the onshoring of drug product manufacture to Massachusetts.

Alkermes will likely proceed with its planned acquisition of Avadel, which experienced an unexpected hitch following Lundbeck ...

Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.

SanegeneBio pipeline features experimental treatments for cardiometabolic conditions, kidney diseases and obesity. Credit: ...

The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

The fund will participate in follow-on and initial rounds, focusing on biotech and medtech ventures across core markets.